Your SlideShare is downloading. ×
Poster
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Poster

310

Published on

Poster presented at International Chemical Biology Society.

Poster presented at International Chemical Biology Society.

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
310
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
11
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. 3D Virtual Screening of PknB Inhibitors using data fusion methods Abhik Seal 1, Perumal Yogeeswari 2, Dharmaranjan Sriram2, David J Wild1,OSDD Consortium 3 1School of Informatics and Computing Indiana University Bloomington USA, 2Department of Pharmacy Birla Institute of Technology Hyderabad Campus, Shameerpet, Hyderbad-500078 India., 3Open Source Drug Discovery, Council of Scientific and Industrial Research, India Datasets : 62 available Inhibitors collected from E-Pharmacophores:E-pharmacophore II was optimizedMycobacterium tuberculosis encodes 11 putative serine- literature, PknB Protein (PDB ID: 2FUM) & 1000 decoy to e-pharmacophore III based on the %yield of actives, • Data fusion algorithms here confirm identification ofthreonine proteins Kinases (STPK) which regulates dataset available from http://www.schrodinger.com/gli specificity and GH score. active compounds “early” in a virtual screeningtranscription, cell development and interaction with the de decoy_set.A validation dataset of 35 actives from 62 process. In this work reciprocal rank has the besthost cells. From the 11 STPKs three kinases namely PknA, performance. and 1000 decoys was prepared.PknB and PknG have been related to the mycobacterial • Data fusion reduces dependency of using a single Tools used: Glide(Docking),E-pharmacophore(Glide XP +growth. PknB sequence identity is less than 27% but the tool for virtual screening.structure showed a very low RMSD of 1.36 Å and 1.72 Å Phase) ,ROCS(Shape Similarity),enrichVS(R package) Pharmacophore: Glide XP descriptors was used for E- • The reciprocal rank algorithm was capable enoughwith eukaryotic kinases. When developing the to select most of the active compounds early in apharmacophore we found that the new compounds pharmacophore generation. E-pharmacophore I and II are from compound I and compound VIII respectively virtual screening process with a very high BEDROCFigure 1 in the pipeline resembles a typical kinase Class I as because these compounds docked top 2 in the score.type pharmacophore. docking program. • Optimization of E-pharmacophore is very crucial to ROCS : 1000 conformations were generated for identify most important sites of a pharmacophore. validation dataset using low energy cut-off of • Random forest models were tested based on the 5(kcal/mol),RMSD (0.6 Å) for duplicate removal as MACCS keys, 2D Pharmacophore fingerprints and suggested by Bostrom etal. Compound VIII was taken CATS descriptors on the Asinex datasets. All the Table 1 Showing different types e-pharmacophore results methods unable to select compounds from 3D as query for ROCS based virtual screening and compounds are scored and ranked based on Tanimoto screening sets showing a possible chance of lead Combo score. hopping in 3D methods. Glide Docking: 2FUM is prepared using Maestro Prime • A list of 45 compounds were finally selected for with water molecules removed. A grid box of 12Å was experimental validation.I used for docking. Fusion Algorithms:The selection of possible pharmacophore was based on • Sum score - The normalized scores of eachthe Enrichment results, %yield of actives, specificity and ranking are summed to get the fused score of aGoodness of Hit list (GHscore). compound • Sum rank - The ranks of each method are Table 2 Showing the statistical measures of structure based summed to get a fused rank of a compound ,ligand based and data fusion methods. • Reciprocal rank - Reciprocal rank combine the normalized scores based on Equation 1. 1 r (Ci ) j 1 pos(Cij ) • Salam etal .J. Chem. Inf. Model. 2009, 49, 2356–2368. Equation1. Reciprocal rank fusion score • Truchon et al.J. Chem. Inf. Model. 2007, 47, 488-508. • Svensson et al.J. Chem. Inf. Model., 2012, 52 (1),225–232Another objective of our screening was how early in a • Nuray, R. etal. Information Processing and Managementvirtual screening run the program can identify actives 42 (2006) 595–614compounds. We used BEDROC and RIE metric to • Zuccotto etal. J.Med Chem 2010,53 2681-2694.determine it.In this work we used pharmacophore, shape basedscreening and docking, scores and ranks as input in datafusion ranking algorithms namely, sum rank, sum score • Indo US Science technology forum forand reciprocal rank. We have identified reciprocal rank providing travel grant and stipend.algorithm performs best in selecting compounds "early" • Open source drug discovery for providingin a virtual screening process. We have also screened the publication charges.Asinex database of 400K compounds with reciprocal rank Figure 3 a)showing the performance metrics of structure • Birla Institute of Technology Hyderabadalgorithm to select potential 45 hits for PknB. and ligand based methods with data fusion. b) PCA plot of . predicted inhibitors with the PknB inhibitors Campus India. Figure 1 Workflow of data fusion 1 st Official conference of the International Chemical Biology Society Oct 4-5 2012 Cambridge, MA, USA

×